From cellular therapy to biologics: non-viral delivery strategies for in vivo CAR-T engineering.
This review provides an overview of the key physiological barriers encountered in in vivo CAR-T cell engineering, alongside the corresponding principles of engineered design and outlines the evolving trends in the chemical composition of delivery materials.